Balanced news tone
News Sentiment
300122 sentiment intelligence
Chongqing Zhifei Biological Products Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
65/100 classification confidence.
directly relevant articles
high-authority source matches
+0.8% over one week, +0.5% over four weeks, trend inactive, and below fair value.
Chongqing Zhifei Biological Products Plans Share Buyback
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Chongqing Zhifei Biological Products Plans Share Buyback
- Tone
- Positive 62/100
- Event
- Capital return
- Published
- 20 Jul 2026 10:41
- Source
- TradingView
Price to sales forward of Chongqing Zhifei Biological Products Co., Ltd. Class A – SZSE:300122
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jul 2026 05:08
- Source
- TradingView
GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 05 Dec 2024 08:00
- Source
- Fierce Pharma
GSK signs shingles vaccine deal with China's Zhifei for around $3 bln
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 09 Oct 2023 07:00
- Source
- Reuters